Green List

31 st edition, 2020
International Narcotics Control Board Annex to the annual statistical report on
psychotropic substances (form P)

List of
Psychotropic Substances
under International Control

In accordance with the

Convention on Psychotropic Substances of 1971

UPDATES

• Inclusion of 10 new substances: DOC in Schedule I; AB-FUBINACA, 5F-AMB-PINACA (5F-AMB,

5F-MMB-PINACA), 5F-MDMB-PICA (5F-MDMB-2201), 4F-MDMB-BINACA, 4-CMC (4-
chloromethcathinone, clephedrone), N-ethylhexedrone and alpha-PHP in Schedule II; flualprazolam
and etizolam in Schedule IV.

The Green List has been prepared by the International Narcotics Control Board to assist Governments in completing the
annual statistical report on psychotropic substances (form P) and the quarterly statistics of imports and exports of
substances in Schedule II of the Convention on Psychotropic Substances of 1971 (form A/P). For information on the names
used for substances under international control and preparations containing such substances, as well as on chemical and
structural formulae and other technical information, see Multilingual Dictionary of Narcotic Drugs and Psychotropic
Substances under International Control. 1

__________________
1 United Nations publication, Sales No. M.06.XI.16.

V.20-03594 (E)

*2003594*
The Green List is divided into three parts:

Part one. Substances in Schedules I, II, III and IV of the Convention on Psychotropic Substances of 1971;

Part two. Pure drug content of bases and salts of psychotropic substances under international control;

Part three. Prohibition of and restrictions on export and import pursuant to article 13 of the Convention on
Psychotropic Substances of 1971.

2
Part one. Substances in Schedules I, II, III and IV of the Convention on
Psychotropic Substances of 1971

Psychotropic substances under international control are presented in the schedules below. Where an international
non-proprietary name (INN) is available for a substance, that I NN is given in the left-hand column. Where no INN is
available, the non-proprietary or trivial names of the substance are given in the second column of the table. Where a trivial
name is commonly applied to a substance with a given INN, then the trivial na me is also given in the second column. Salts
of all the substances covered by the four schedules, whenever the existence of such salts is possible, are also under
international control.
For other names, synonyms or trade names apply either to pure psychotr opic substances, the salts of psychotropic
substances or to preparations containing either the pure substance or its salt form, see Multilingual Dictionary of Narcotic
Drugs and Psychotropic Substances under International Control. 2

The following interpretation guidelines 3 concerning the stereoisomers of substances in Schedules II, III and IV of the 1971
Convention 4 were developed, pursuant to Commission on Narcotic Drugs decision 42/2, in order to clarify the scope of
control of stereoisomers of substances in those schedules:
(a) When the substance listed can exist as stereochemical variants the following should apply:
(i) If the chemical designation of the substance used in the 1971 Convention (or in a subsequent scheduling
decision of the Commission on Narcotic Drugs) does not include any stereochemical descriptors or indicates a
racemic form of the substance:
a. If the molecule contains one chiral centre, both the R- and S-enantiomers and the RS-racemate are
controlled, unless specifically excepted by a decision of the Commission on Narcotic Drugs;
b. If the molecule contains more than one chiral centre, all the diastereoisomers and their racemic pairs
are controlled, unless specifically excepted by a decision of the Commission on Narcotic Drugs;
(ii) If the chemical designation used in the 1971 Convention (or in a subsequ ent scheduling decision of the
Commission on Narcotic Drugs) for the substance which contains one chiral centre in the molecule includes a
stereochemical descriptor indicating a specific enantiomer, the racemic form of the substance is also controlled,
unless specifically excepted by a decision of the Commission on Narcotic Drugs, while the other enantiomer
is not controlled;
(iii) If the chemical designation used in the 1971 Convention (or in a subsequent scheduling decision of the
Commission on Narcotic Drugs) for the substance which contains more than one chiral centre in the molecule
includes stereochemical descriptors indicating a specific diastereoisomer, only that diaster eoisomer is
controlled;
(b) When one enantiomer is controlled, then a mixture of that enantiomer with the other enantiomeric substance is
controlled;
(c) The chemical designations and INNs used in the scheduling decisions to define substances in Schedule s II, III
and IV of the 1971 Convention were considered appropriate at the time s when such decisions were made. It
should be understood that:
(i) Alternative chemical designations constructed according to modified chemical nomenclature rules may
be used in official documents as long as they preserve the stereospecificity when appro priate;
(ii) If any subsequent modification of an INN definition uses a chemical designation which is different to that
in the scheduling decision, such an INN should be omitted from official documents.

__________________
2 United Nations publication, Sales No. M.06.XI.16.
3 The guidelines are also applicable to the stereoisomers of substances in Schedule I, whenever the existence of such stereoisomers is
possible within the specific chemical designation, which are under international control unless specificall y excepted by a decision
of the Commission on Narcotic Drugs.
4 WHO Expert Committee on Drug Dependence: Thirty-second Report, WHO Technical Report Series No. 903 (Geneva, World
Health Organization, 2001), annex.
3
In order to facilitate rapid identification of all scheduled psychotropic substances, CAS (Chemical Abstracts Service)
registry numbers were included for the most traded substances (Schedule II, III and IV substances) and their salts. The list
is not exhaustive and the absence of a CAS number does not mean that it does not exist but rather that it was not available at the
time of the update of the list. CAS numbers were included in the following cases:
(i) The substance under international control exists in the base form and stereoisomer variants do not exist, i.e., it is
a unique CAS number.
(ii) If stereoisomers exist within the specific chemical designation: if stereoisomers and racemic mixture are already
listed and related CAS numbers are available (example: amphetamine, dexamfetamine and levamfetamine).

4
 Substances in Schedule I

Other
International non-proprietary
IDS Codes non-proprietary name or trivial names Chemical name

PC 010 CATHINONE (–)-(S)-2-aminopropiophenone

PD 001 DET 3-[2-(diethylamino)ethyl]indole
3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
PD 003 DMHP dibenzo[b,d]pyran-1-ol
PD 004 DMT 3-[2-(dimethylamino)ethyl]indole
PD 007 DMA (±)-2,5-dimethoxy-α-methylphenethylamine
PD 008 DOET (±)-4-ethyl-2,5-dimethoxy-α-methylphenethylamine
PD 009 BROLAMFETAMINE DOB (±)-4-bromo-2,5-dimethoxy-α-methylphenethylamine
PD 011 DOC 4-Chloro-2,5-dimethoxyamfetamine
PE 006 ETRYPTAMINE 3-(2-aminobutyl)indole
PL 002 (+)-LYSERGIDE LSD, LSD-25 9,10-didehydro-N,N-diethyl-6-methylergoline-8β-carboxamide
PM 004 mescaline 3,4,5-trimethoxyphenethylamine
PM 011 MDMA (±)-N,α-dimethyl-3,4-(methylenedioxy)phenethylamine
PM 013 MMDA 5-methoxy-α-methyl-3,4-(methylenedioxy)phenethylamine
PM 014 TENAMFETAMINE MDA α-methyl-3,4-(methylenedioxy)phenethylamine
PM 017 4-methylaminorex (±)-cis-2-amino-4-methyl-5-phenyl-2-oxazoline
PM 019 methcathinone 2-(methylamino)-1-phenylpropan-1-one
PM 020 4-MTA α-methyl-4-methylthiophenethylamine
PN 004 N-ethyl MDA, MDEA (±)-N-ethyl-α-methyl-3,4-(methylenedioxy)phenethylamine
PN 005 N-hydroxy MDA (±)-N[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine
PN 006 25B-NBOMe 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
PN 007 25C-NBOMe 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
PN 008 25I-NBOMe 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
PP 001 parahexyl 3-hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol
PP 003 ETICYCLIDINE PCE N-ethyl-1-phenylcyclohexylamine
PP 007 ROLICYCLIDINE PHP, PCPY 1-(1-phenylcyclohexyl)pyrrolidine
PP 012 psilocine, psilotsin 3-[2-(dimethylamino)ethyl]indol-4-ol
PP 013 PSILOCYBINE 3-[2-(dimethylamino)ethyl]indol-4-yl dihydrogen phosphate
PP 017 PMA 1-(4-methoxyphenyl)propan-2-amine
PP 021 PMMA 1-(4-methoxyphenyl)-2-methylaminopropane
PS 002 STP, DOM 2,5-dimethoxy-α,4-dimethylphenethylamine
PT 001 TENOCYCLIDINE TCP 1-[1-(2-thienyl)cyclohexyl]piperidine
PT 002 TETRAHYDRO- THC tetrahydrocannabinol, the following isomers and their stereochemical
CANNABINOL variants:
delta-6a(10a)-THC 7,8,9,10-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
(9R,10aR)-8,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-
delta-6a(7)-THC dibenzo[b,d]pyran-1-ol
(6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-
delta-7-THC dibenzo[b,d]pyran-1-ol
(6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-
delta-8-THC dibenzo[b,d]pyran-1-ol
delta-10-THC 6a,7,8,9-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
(6aR,10aR)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-methylene3-
delta-9(11)-THC pentyl-6H-dibenzo[b,d]pyran-1-ol
PT 006 TMA (±)-3,4,5-trimethoxy-α-methylphenethylamine

The stereoisomers of substances in Schedule I are also controlled, unless specifically excepted, whenever the existence of such stereoisomers is
possible within the specific chemical designation.

5
 Substances in Schedule II

International Other non-proprietary

IDS Codes CAS Number non-proprietary name or trivial names Chemical name

PA 003 300-62-9 AMFETAMINE amphetamine (±)-α-methylphenethylamine

PA 007 57574-09-1 AMINEPTINE 7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-
5-yl)amino]heptanoic acid
PA 008 335161-24-5 AM-2201, JWH-2201 [1-(5-Fluoropentyl)-1H-indol-3-yl](naphthalen-
1-yl)methanone
PA 009 1400742-13-3 5F-APINACA, 5F- N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-
AKB-48 carboxamide
PA 010 1801552-03-3 5F-AMB, 5F-AMB- Methyl 2-({[1-(5-fluoropentyl)-1H-indazol-
PINACA 3yl]carbonyl}amino)-3-methylbutanoate
PB 008 66142-81-2 2C-B 4-bromo-2,5-dimethoxyphenethylamine
PC 011 AB-CHMINACA N-[(2S)-1-amino-3-methyl-oxobutan-2-yl]-1-
(cyclohexylmethyl)-1H-indazole-3-
carboxamide
PC 012 1631074-54-8 CUMYL-4CN- 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-
BINACA indazole-3-carboxamide
PC 013 ADB-CHMINACA, N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-
MAB-CHMINACA yl]-1-(cyclohexylmethyl)-1H-indazole-3-
carboxamide
PC 014 1225843-86-6 4-CMC (4- clephedrone 1-(4-chlorophenyl)-2-(methylamino)-1-
chloromethcathinone ) propanone
PD 002 51-64-9 DEXAMFETAMINE dexamphetamine (+)-α-methylphenethylamine
PD 010 DRONABINOLa delta-9-tetrahydro- (6aR,10aR)-6a,7,8,10a-tetrahydro-6,6,9-
cannabinol and its trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-
stereochemical 1-ol
variants
PE 007 1112937-64-0 ethylone (RS)-1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-
one
PE 008 57413-43-1 ethylphenidate ethyl 2-phenyl-2-piperidin-2-ylacetate [1]
PF 005 3736-08-1 FENETYLLINE 7-[2-[(α-methylphenethyl)amino]ethyl]theophylline
PF 007 4-fluoroamphetamine, 1-(4-Fluorophenyl)propan-2-amine
4-FA
PF 008 1971007-92-7 FUB-AMB, MMB- Methyl(2S)-2-({1-[4-fluorophenyl]methyl-1H-
FUBINACA, AMB- indazole-3-carbonyl }amino)-3-
FUBINACA methylbutanoate
PF 009 1445583-51-6 ADB-FUBINACA N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-
yl]-1-[(4-fluorophenyl)methyl]-1H-
indazole-3-carboxamide
PF 010 1185282-01-2 AB-FUBINACA N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-
[(4-fluorophenyl)methyl]indazole-3-
carboxamide
PG 002 591-81-1 gamma-HYDROXYBUTIRIC GHB γ-hydroxybutyric acid
ACID
PJ 001 209414-07-3 JWH-018, AM-678 Naphthalene-1-yl(1-pentyl-1H-indol-3-
yl)methanone
PL 006 156-34-3 LEVAMFETAMINE levamphetamine (–)-(R)-α-methylphenethylamine(amphetamine(-
)isomer
PL 007 33817-09-3 LEVMETAMFETAMINE levomethamphetamine (–)-N,α-dimethylphenethylamine
PM 002 340-57-8 MECLOQUALONE 3-(o-chlorophenyl)-2-methyl-4(3H)-
quinazolinone
PM 005 537-46-2 METAMFETAMINE methamphetamine (+)-(S)-N,α-dimethylphenethylamine
PM 006 72-44-6 METHAQUALONE 2-methyl-3-o-tolyl-4(3H)-quinazolinone
PM 007 113-45-1 METHYLPHENIDATE methyl α-phenyl-2-piperidine acetate
PM 015 7632-10-2 METAMFETAMINE methamphetamine (±)-N,α-dimethylphenethylamine
RACEMATE racemate

6
 International Other non-proprietary
IDS Codes CAS Number non-proprietary name or trivial names Chemical name
PM 021 687603-66-3 MDPV, 3,4- (RS)-1-(Benzo[d][1,3]dioxol-5-yl)-2-
methylenedioxypyrov (pyrrolidin-1-yl)pentan-1-one
alerone
PM 022 1189805-46-6 mephedrone, 4- (RS)-2-methylamino-1-(4-methylphenyl)propan-
methylmethcathinone 1-one
PM 023 186028-79-5N methylone, beta-keto- (RS)-2-methylamino-1-(3,4-
MDMA methylenedioxyphenyl)propan-1-one
PM 024 1239943-76-0 methoxetamine, (RS)-2-(3-methoxyphenyl)-2-(ethylamino)-
MXE cyclohexanone
PM 025 1863065-84-2 MDMB-CHMICA methyl 2-[[1-(cyclohexylmethyl)indole-3-
carbonyl]amino]-3,3dimethylbutanoate
PM 026 801156-47-8 methiopropamine, 1-(thiophen-2-yl)-2-methylaminopropane
MPA
PM 027 1225617-18-4 4-methylethcathinone, 2-(Ethylamino)-1-(4-methylphenyl)propan-1-one
4-MEC
PM 028 1971007-88-1 5F-MDMB-PICA Methyl(S)-2-(1-(5-fluoropentyl)-1H-indole-3-
carboxamido)-3,3-dimethylbutanoate
PM 029 4F-MDMB-BINACA Methyl(S)-2-(1-(4-fluorobutyl)-1H-indazole-3-
carboxamido)-3,3-dimethylbutanoate
PN 009 2759-28-6 N-benzylpiperazine, 1-benzylpiperazine
benzylpiperazine,
BZP
PN 010 952016-47-6 N-ethylnorpentylone 1-(2H-1,3-benzodioxol-5-yl)-2-
(ethylamino)pentan-1-one
PN 011 802857-66-5 N-ethylhexedrone 2-(Ethylamino)-1-phenyl-1-hexanone
PP 005 77-10-1 PHENCYCLIDINE PCP 1-(1-phenylcyclohexyl)piperidine
PP 006 134-496 PHENMETRAZINE 3-methyl-2-phenylmorpholine
PP 011 1715016-75-3 5F-ADB, 5F-MDMB- Methyl(2S)-2-{[1-(fluoropentyl)-1H-indazole-3-
PINACA carbonyl]amino}-3,3-dimethylbutanoate
PP 018 1445583-20-9 AB-PINACA N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-
pentyl-1H-indazole-3-carboxamide
PP 022 14530-33-7 alpha-PVP α-pyrrolidinovalerophenone
PP 023 364064-08-4 4,4’-DMAR, 4,4’- para-methyl-4-methylaminorex
dimethylaminorex
PP 025 879722-57-3 pentedrone (±)-2-(methylamino)-1-phenylpentan-1-one
PP 026 1400742-41-7 5F-PB-22 Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-
carboxylate
PP 027 13415-86-6 alpha-PHP (RS)-1-Phenyl-2-(pyrrolidine-1-yl)hexan-1-one
PS 001 76-73-3 SECOBARBITAL 5-allyl-5-(1-methylbutyl)barbituric acid
PU 001 1199943-44-6 UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-
tetramethylcyclopropoyl)methanone
PX 001 1364933-54-9 XLR-11 [1-(5-Fluoropentyl)-1H-indol-3-
yl](2,2,3,3tetramethylcyclopropyl)methanone
PZ 001 34758-83-3 ZIPEPROL α-(α-methoxybenzyl)-4-(β-methoxyphenethyl)-
1-piperazineethanol
a This international non-proprietary name refers to only one of the stereochemical variants of delta-9-tetrahydrocannabinol,
namely (-)-trans-delta-9-tetrahydrocannabinol.

7
 Substances in Schedule III

International Other non-proprietary

IDS Codes CAS Number non-proprietary name or trivial names Chemical name

PA 002 57-43-2 AMOBARBITAL 5-ethyl-5-isopentylbarbituric acid

PB 004 77-26-9 BUTALBITAL 5-allyl-5-isobutylbarbituric acid
PB 006 52485-79-7 BUPRENORPHINE 2l-cyclopropyl-7-α-[(S)-1-hydroxy-1,2,2-
trimethylpropyl]-6,14-endo-ethano-6,7,8,14-
tetrahydrooripavine
PC 001 52-31-3 CYCLOBARBITAL 5-(1-cyclohexen-1-yl)-5-ethylbarbituric acid
PC 009 492-39-7 CATHINE (+)- (+)-(S)-α-[(S)-1-aminoethyl]benzyl alcohol
norpseudoephedrine
PF 002 1622-62-4 FLUNITRAZEPAM 5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-
1,4-benzodiazepin-2-one
PG 001 77-21-4 GLUTETHIMIDE 2-ethyl-2-phenylglutarimide
PP 002 76-74-4 PENTOBARBITAL 5-ethyl-5-(1-methylbutyl)barbituric acid
PP 014 55643-30-6 PENTAZOCINE (2R*,6R*,11R*)-1,2,3,4,5,6-hexahydro-6,11-
dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-
3-benzazocin-8-ol

8
 Substances in Schedule IV

International Other non-proprietary

IDS Codes CAS Number non-proprietary name or trivial names Chemical name

PA 001 90-84-6 AMFEPRAMONE diethylpropion 2-(diethylamino)propiophenone

PA 004 28981-97-7 ALPRAZOLAM 8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-
a][1,4]benzodiazepine
PA 005 52-43-7 ALLOBARBITAL 5,5-diallylbarbituric acid
PA 006 2207-50-3 AMINOREX 2-amino-5-phenyl-2-oxazoline
PB 001 57-44-3 BARBITAL 5,5-diethylbarbituric acid
PB 002 156-08-1 BENZFETAMINE benzphetamine N-benzyl-N,α-dimethylphenethylamine
PB 003 1812-30-2 BROMAZEPAM 7-bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-
benzodiazepin-2-one
PB 005 77-28-1 BUTOBARBITAL butobarbitone 5-butyl-5-ethylbarbituricacid
PB 007 57801-81-7 BROTIZOLAM 2-bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-
f]-s-triazolo[4,3-a][1,4]diazepine
PC 002 36104-80-0 CAMAZEPAM 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-
2H-1,4-benzodiazepin-2-
one dimethylcarbamate (ester)
PC 003 58-25-3 CHLORDIAZEPOXIDE 7-chloro-2-(methylamino)-5-phenyl-3H-1,4-
benzodiazepine-4-oxide
PC 004 22316-47-8 CLOBAZAM 7-chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-
2,4(3H,5H)-dione
PC 005 1622-61-3 CLONAZEPAM 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-
benzodiazepin-2-one
PC 006 23887-31-2 CLORAZEPATE 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-
benzodiazepine-3-carboxylic acid
PC 007 33671-46-4 CLOTIAZEPAM 5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H-
thieno[2,3-e]-1,4-diazepin-2-one
PC 008 24166-13-0 CLOXAZOLAM 10-chloro-11b-(o-chlorophenyl)-2,3,7,11b-tetrahydro-
oxazolo-[3,2-d][1,4]benzodiazepin-6(5H)-one
PD 005 2894-67-9 DELORAZEPAM 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-2H-1,4-
benzodiazepin-2-one
PD 006 439-14-5 DIAZEPAM 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-
benzodiazepin-2-one
PE 001 113-18-8 ETHCHLORVYNOL 1-chloro-3-ethyl-1-penten-4-yn-3-ol
PE 002 126-52-3 ETHINAMATE 1-ethynylcyclohexanolcarbamate
PE 003 29975-16-4 ESTAZOLAM 8-chloro-6-phenyl-4H-s-triazolo[4,3-
a][1,4]benzodiazepine
PE 004 29177-84-2 ETHYL LOFLAZEPATE ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-
1H-1,4-benzodiazepine-3-carboxylate
PE 005 457-87-4 ETILAMFETAMINE N-ethylamphetamine N-ethyl-α-methylphenethylamine
PE 009 0040054-69-1 ETIZOLAM 4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-
f][1,2,4]triazolo[4,3a][1,4]diazepine
PF 001 3900-31-0 FLUDIAZEPAM 7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-2H-
1,4-benzodiazepin-2-one
PF 003 17617-23-1 FLURAZEPAM 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-
1,3-dihydro-2H-1,4-benzodiazepin-2-one
PF 004 1209-98-9 FENCAMFAMIN N-ethyl-3-phenyl-2-norbornanamine
PF 006 16397-28-7 FENPROPOREX (±)-3-[(α-methylphenylethyl)amino]propionitrile
PF 011 28910-91-0 flualprazolam 8-Chloro-6-(2-fluoro-phenyl)-1-methyl-4h-
benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepime
PH 001 23092-17-3 HALAZEPAM 7-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-
2H-1,4-benzodiazepin-2-one
PH 002 59128-97-1 HALOXAZOLAM 10-bromo-11b-(o-fluorophenyl)-2,3,7,11b-
tetrahydrooxazolo[3,2-d] [1,4]benzodiazepin-
6(5H)-one

9
 International Other non-proprietary
IDS Codes CAS Number non-proprietary name or trivial names Chemical name
PK 001 27223-35-4 KETAZOLAM 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-
[1,3]oxazino[3,2-d][1,4]benzodiazepin-4,7(6H)-
dione
PL 001 7262-75-1 LEFETAMINE SPA (–)-N,N-dimethyl-1,2-diphenylethylamine
PL 003 61197-73-7 LOPRAZOLAM 6-(o-chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-
piperazinyl)methylene]-8-nitro-1H-imidazo[1,2-
a][1,4]benzodiazepin-1-one
PL 004 846-49-1 LORAZEPAM 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-
1,4-benzodiazepin-2-one
PL 005 848-75-9 LORMETAZEPAM 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1-
methyl-2H-1,4-benzodiazepin-2-one
PM 001 22232-71-9 MAZINDOL 5-(p-chlorophenyl)-2,5-dihydro-3H-imidazo[2,1-
a]isoindol-5-ol
PM 003 57-53-4 MEPROBAMATE 2-methyl-2-propyl-1,3-propanedioldicarbamate
PM 008 115-38-8 METHYLPHENOBARBITAL 5-ethyl-1-methyl-5-phenylbarbituric acid
PM 009 125-64-4 METHYPRYLON 3,3-diethyl-5-methyl-2,4-piperidine-dione
PM 010 2898-12-6 MEDAZEPAM 7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-
benzodiazepine
PM 012 17243-57-1 MEFENOREX N-(3-chloropropyl)-α-methylphenethylamine
PM 016 59467-70-8 MIDAZOLAM 8-chloro-6-(o-fluorophenyl)-1-methyl-4H-
imidazo[1,5- a][1,4]benzodiazepine
PM 018 34262-84-5 MESOCARB 3-(α-methylphenethyl)-N-
(phenylcarbamoyl)sydnone imine
PN 001 2011-67-8 NIMETAZEPAM 1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-
benzodiazepin-2-one
PN 002 146-22-5 NITRAZEPAM 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-
2-one
PN 003 1088-11-5 NORDAZEPAM 7-chloro-1,3-dihydro-5-phenyl-2H-1,4-
benzodiazepin-2-one
PO 001 604-75-1 OXAZEPAM 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-
benzodiazepin-2-one
PO 002 24143-17-7 OXAZOLAM 10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-
phenyloxazolo[3,2-d][1,4]benzodiazepin-
6(5H)-one
PP 004 634-03-7 PHENDIMETRAZINE (+)-(2S,3S)-3,4-dimethyl-2-phenylmorpholine
PP 008 50-06-6 PHENOBARBITAL 5-ethyl-5-phenylbarbituric acid
PP 009 122-09-8 PHENTERMINE α,α-dimethylphenethylamine
PP 010 467-60-7 PIPRADROL 1,1-diphenyl-1-(2-piperidyl)methanol
PP 015 52463-83-9 PINAZEPAM 7-chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-2H-
1,4-benzodiazepin-2-one
PP 016 2955-38-6 PRAZEPAM 7-chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-
phenyl-2H-1,4-benzodiazepin-2-one
PP 019 3563-49-3 PYROVALERONE 4’-methyl-2-(1-pyrrolidinyl)valerophenone
PP 020 2152-34-3 PEMOLINE 2-amino-5-phenyl-2-oxazolin-4-one
PP 024 51753-57-2 phenazepam, 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-
fenazepam benzodiazepin-2-one

PS 003 125-40-6 SECBUTABARBITAL 5-sec-butyl-5-ethylbarbituric acid

PT 003 846-50-4 TEMAZEPAM 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-
2H-1,4-benzodiazepin-2-one
PT 004 10379-14-3 TETRAZEPAM 7-chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1-
methyl-2H-1,4-benzodiazepin-2-one
PT 005 28911-01-5 TRIAZOLAM 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-
triazolo[4,3- a][1,4] benzodiazepine

10
 International Other non-proprietary
IDS Codes CAS Number non-proprietary name or trivial names Chemical name
PV 001 2430-49-1 VINYLBITAL 5-(1-methylbutyl)-5-vinylbarbituric acid
PZ 002 82626-48-0 ZOLPIDEM N,N,6-trimethyl-2-p-tolylimidazo[1,2-a]pyridine-3-
acetamide

11
Part two. Pure drug content of bases and salts of psychotropic substances under
international control

Psychotropic substance Base or salt CAS Number Theoretical percentage of anhydrous base

25B-NBOMe Hydrochloride 1539266-15-3 91.3

25C-NBOMe Hydrochloride 1539266-19-7 90.2
25I-NBOMe Hydrochloride 1043868-97-8 92.1
AH-7921 Hydrochloride 41804-96-0 90.0
Allobarbital Aminophenazone 58-15-1 50.6
Amfepramone Glutamate 58.3
Hydrochloride 134-80-5 84.9
Resinate 100.0
Amfetamine Acetylsalicylate 42.9
Adipate 48.1
Aspartate 50.4
Aspartate monohydrate 851591-76-9 64.2
Bitartrate 47.0
Hydrochloride 27-06-50-5 79.2
Para-aminophencylacetate 47.2
Parachlorophenoxyacetate 42.0
Pentobarbiturate 37.4
Phosphate (1 mol. base) 139-10-6 58.0
Phosphate (2 mol. base) 73.4
Resinate —
Sulfate (2 mol. base) 60-10-6 73.4
Tannate 29.6
Tartrate (2 mol. base) 64.3
Amineptine Hydrochloride 90.2
Aminorex Fumarate 13425-22-4 58.3
Hydrochloride 81.7
Amobarbital Resinate —
Sodium 64-43-7 91.1
N-benzylpiperazine (BZP) Dihydrochloride 5321-63-1 70.8
Hydrochloride 72-878-35-4 82.9
Barbital Calcium (2 mol. base) 90.6
Magnesium (2 mol. base) 94.3
Sodium 144-02-3 89.3
Benzfetamine Hydrochloride 5411-22-3 86.8
Brolamfetamine (DOB) Hydrochloride 29705-96-2 88.3
Buprenorphine Bitartrate 76.0
Hydrochloride 53152-21-9 92.8
Sulfate (2 mol. base) 91.0
2-CB Hydrochloride 56281-37-9 87.7
Cathinone Hydrochloride 80.3
Cathine Hydrochloride 2153-98-2 80.6
Phenobarbiturate 39.4
Resinate —
Sulfate (2 mol. base) 75.5
Chlordiazepoxide Dibunate 48.3
Hydrochloride 438-41-5 89.1

12
Psychotropic substance Base or salt CAS Number Theoretical percentage of anhydrous base
Clorazepate Dipotassium 57109-90-7 76.9
Monopotassium 5991-71-9 89.2
Cyclobarbital Calcium (2 mol. base) 143-76-0 92.5
DET Hydrochloride 7558-72-7 85.6
Dexamfetamine Adipate 48.1
Carboxymethylcellulose —
Hydrochloride 1462-73-3 79.2
Pentobarbiturate 37.4
Phosphate (2 mol. base) 73.4
Phosphate 7528-0-9 58.0
Resinate —
Saccharate (monobasic) 39.1
Sulfate (2 mol. base) 51-63-8 73.4
Tannate 29.6
Tartrate 47.4
DMA Hydrochloride 84.2
DMT Hydrochloride 83.8
Methyliodide 57.0
DOET Hydrochloride 22139-65-7 85.9
Etilamfetamine Hydrochloride 16105-78-5 81.7
Eticyclidine Hydrochloride 84.8
Etryptamine Acetate 118-68-3 75.8
Hydrochloride 83.8
Fencamfamin Hydrochloride 2240-14-4 85.5
Fenetylline Hydrochloride 1892-80-4 90.3
Fenproporex Diphenylacetate 77816-15-0 47.0
Hydrochloride 16359-54-9 83.8
Resinate —
Flurazepam Dihydrochloride 84.2
Hydrochloride 36105-20-1 91.0
gamma-Hydroxybutyric acid Sodium 502-85-2 83.0
N-ethyl MDA Hydrochloride 74341-83-6 85.0
N-hydroxy MDA Hydrochloride 74341-83-6 84.2
Lefetamine (SPA) Hydrochloride 14148-99-3 86.0
Levamfetamine Alginate —
Succinate 5634-40-2 53.4
Sulfate 51-62-7 73.4
Levomethamphetamine Hydrochloride 80.3
Loprazolam Mesilate 70111-54-5 82.9
Methylsulfonate (1 H2O) 80.3
Lorazepam Acetate 84.0
Mesilate 77.0
Pivalate 57773-81-6 75.9
(+) Lysergide Tartrate (2 mol. base, 2 CH3OH) 75.1
Tartrate (2 mol. base, 2 H2O) 77.7
MDMA Hydrochloride 92279-84-0 84.2
Mecloqualone Hydrochloride 88.2
Medazepam Dibunate 45.8

13
Psychotropic substance Base or salt CAS Number Theoretical percentage of anhydrous base
Hydrochloride 2898-11-5 88.2
Mefenorex Hydrochloride 5586-87-8 85.3
Mescaline Aurichloride (1 H2O) 6533-56-8 37.1
Hydrochloride 832-92-8 85.3
Picrate 5967-44-2 48.0
Platinichloride (2 mol. base) 36.1
Sulfate 68.3
Sulfate (2 mol. base, 2 H2O) 75.9
Mephedrone Hydrochloride 1189726-22-4 82.9
MDPV Hydrochloride 24622-62-6 88.3
Metamfetamine Tartrate 49.9
Hydrochloride 51-57-0 80.4
Sulfate (2 mol. base) 75.2
Metamphetanmine racemate Hydrochloride 300-42-5 80.4
Methaqualone Hydrochloride 340-56-7 87.3
Resinate —
Methcathinone Hydrochloride 49656-78-2 81.1
Methoxetamine (MXE) Hydrochloride 87.2
4-Methylaminorex Hydrochloride 82.8
Methylone Hydrochloride 186028-80-8 85.0
Methylphenidate Hydrochloride 298-59-9 86.5
Methylphenobarbital Sodium 91.8
Midazolam Hydrochloride 59467-96-8 89.9
Maleate 59467-94-6 73.7
MMDA Hydrochloride 85.0
4-MTA Hydrochloride 83.2
Oxazepam Acetate 83.0
Hemisuccinate 82.9
Succinate 70.8
Valproate 66.5
Pemoline Copper 64.4
Iron 58.7
Magnesium 18968-99-5 75.1
Nickel 57.8
Pentazocine Hydrochloride 2276-52-0 88.7
Lactate 76.0
Pentobarbital Calcium (2 mol. base) 92.2
Sodium 57-33-0 91.1
Phencyclidine Hydrobromide 75.1
Hydrochloride 956-90-1 87.0
Phendimetrazine Tartrate 50-58-8 56.0
Hydrochloride 7635-51-0 84.0
Pamoate 49.6
Phenmetrazine Tartrate 54.1
Hydrochloride 1707-14-8 82.9
Sulfate (2 mol. base) 78.3
Theoclate 13931-75-4 45.2

14
Psychotropic substance Base or salt CAS Number Theoretical percentage of anhydrous base
Phenobarbital Ammonium 93.2
Calcium (2 mol. base) 7645-06-9 92.4
Diethylamine 76.0
Diethylaminoethanol 66.5
Lysidine 73.4
Magnesium (2 mol. base) 95.4
Propylhexedrine 59.9
Quinidine 77-86-1 41.7
Sodium 9010-10-0 91.4
Sodium-magnesium (3 mol. base) 94.0
Sparteine (2 mol. base) 66.5
Tetramethylammonium 75.6
Yohimbine 39.6
Phentermine Hydrochloride 1197-21-3 80.4
Resinate —
Pipradrol Hydrochloride (1 H2O) 71-78-3 88.0
PMA Hydrochloride 64-13-1 81.9
PMMA (para- Hydrochloride 83.1
methoxymethylamphetamine)
Psilocine Hydrochloride 85.0
Psilocybine Base (1 CH3OH) 90.0
Hydrochloride 88.6
Pyrovalerone Hydrochloride 1147-62-2 87.1
alpha-Pyrrolidinovalerophenone Hydrochloride 86.4
(α PVP)
Secbutabarbital Sodium 143-81-7 90.6
Secobarbital Calcium 86.3
Resinate —
Sodium 91.6
STP, DOM Hydrochloride 15589-00-1 85.2
Tenamfetamine (MDA) Hydrochloride 6292-917 83.1
Tenocyclidine Hydrochloride 1867-65-8 87.2
TMA Hydrochloride 593-81-7 86.1
Zipeprol Dihydrochloride 34758-84-4 84.1
Zolpidem Hemitartrate 99294-93-6 80.2

15
Part three. Prohibition of and restrictions on export and import pursuant to article 13 of the
Convention on Psychotropic Substances of 1971

The Secretary-General has transmitted notifications concerning the prohibition of the importation of specific substances
in Schedules II, III and IV of the 1971 Convention that were received from the countries listed below. In the first table
presented below, the notifying countries are listed alphabetically, followed by the names of the prohibited substances and
dates of notification. In the second table presented below, the prohibited substances are listed alphabetically, followed by
the names of the notifying countries. The prohibitions are effective, with respect to exporting countries, as at the date of
receipt of the Secretary-General’s notification.
Note to exporting countries
Upon notification of a prohibition, a country must take measures to ensure that none of the substances specified in the
notification is exported to the notifying country or any of its regions. Exports of the prohibited substance may be permitted
only when a special import licence has been issued by the notifying country, in accordance with the provisions of
article 13 of the 1971 Convention.

Notifications concerning the prohibition of and restrictions on export and import pursuant to
article 13 of the Convention on Psychotropic Substances 1971, by notifying country

Date of notification by the

Notifying country Prohibited substance Secretary-General

Argentina Mecloqualone 15 January 1987

Methaqualone 24 March 1982
Australia Methaqualone 8 August 1980
Belize Amfetamine 9 May 1989
Dexamfetamine
Fenetylline
Levamfetamine
Levomethamphetamine
Mecloqualone
Metamfetamine
Metamfetamine racemate
Methaqualone
Methylphenidate
Phencyclidine (PCP)
Phenmetrazine
Secobarbital
Bulgaria Amfetamine 12 August 1993
Dexamfetamine
Fenetylline
Levamfetamine
Metamfetamine
Metamfetamine racemate
Chile Glutethimide 1 July 1981
Lefetamine (SPA)
Mecloqualone
Methaqualone
Phencyclidine
Phenmetrazine
Colombia Methaqualone 11 November 1981
Gabon Methaqualone 28 July 1993
Iceland Phencyclidine 28 November 1979

16
 Date of notification by the
Notifying country Prohibited substance Secretary-General
India Amfepramone 30 May 1991
Aminorex 27 October 2005
Benzfetamine 30 May 1991
Bromazepam
Brotizolam 27 October 2005
Camazepam 30 May 1991
Clotiazepam
Cloxazolam
Delorazepam
Estazolam
Ethinamate
Ethyl loflazepate
Fludiazepam
Flunitrazepam
Haloxazolam
Ketazolam
Lefetamine (SPA)
Loprazolam
Lormetazepam
Mazindol
Medazepam
Mesocarb 27 October 2005
Methaqualone 30 April 1993
Methyprylon 30 May 1991
Oxazolam 30 May 1991
Phendimetrazine
Pinazepam 30 May 1991
Pipradrol
Prazepam
Temazepam
Tetrazepam
Japan Amfetamine 31 January 1991
Dexamfetamine
Levamfetamine
Levomethamphetamine
Metamfetamine
Metamfetamine racemate
Latvia Amfetamine 7 November 1995
Cathine
Dexamfetamine
Etilamfetamine
Fenetylline
Fenproporex
Levamfetamine
Mefenorex
Metamfetamine
Metamfetamine racemate
Phentermine

17
 Date of notification by the
Notifying country Prohibited substance Secretary-General
Lebanon Amfetamine 16 October 2000
Benzfetamine 21 August 2007
Cathine 16 October 2000
delta-9-tetrahydrocannabinol
Dexamfetamine
Fenetylline
Flunitrazepam 21 August 2007
Levamfetamine 16 October 2000
Levomethamphetamine
Mecloqualone
Metamfetamine
Metamfetamine racemate
Methaqualone
Phencyclidine
Triazolam 21 August 2007
Lithuania Amfetamine 29 August 1997
Cathine
Dexamfetamine
Fenetylline
Levamfetamine
Metamfetamine
Metamfetamine racemate
Madagascar Methaqualone 15 December 1978
Nigeria Amfetamine 27 February 1986
Dexamfetamine
Metamfetamine
Methaqualone
Methylphenidate
Pemoline 29 October 1990
Phencyclidine 27 February 1986
Phenmetrazine
Secobarbital
Pakistan Amfepramone 6 December 1985
Amfetamine
Barbital
Benzfetamine
Camazepam
Clotiazepam
Cloxazolam
Cyclobarbital
Delorazepam
Dexamfetamine
Ethchlorvynol
Ethinamate
Ethyl loflazepate
Flunitrazepam
Flurazepam
Glutethimide
Halazepam

18
 Date of notification by the
Notifying country Prohibited substance Secretary-General
Pakistan (continued) Haloxazolam
Lefetamine (SPA)
Loprazolam
Mazindol
Mecloqualone
Metamfetamine
Methaqualone
Methylphenobarbital
Methyprylon
Nordazepam
Oxazolam
Phencyclidine
Phendimetrazine
Phenmetrazine
Pipradrol
Secobarbital
Tetrazepam
Peru Lefetamine 7 April 2005
Phendimetrazine 8 April 2005
Russian Federation Cathine 9 November 2005
Saudi Arabia Fenetylline 31 December 1987
Methaqualone
Senegal Amfetamine 16 May 1980
Dexamfetamine
Mecloqualone 31 January 1991
Metamfetamine 16 May 1980
Methaqualone
Methylphenidate
Phencyclidine
Phenmetrazine
South Africa Methaqualone 15 December 1978
Thailand Amfetamine 15 August 1991
Dexamfetamine
Fenetylline
Levamfetamine
Levomethamphetamine
Metamfetamine
Methylphenidate
Phenmetrazine 15 August 1991
Togo Amfetamine 28 July 1993
Ethinamate
Lefetamine (SPA)
Mecloqualone
Metamfetamine
Methylphenidate
Methylphenobarbital
Methyprylon
Pemoline
Phencyclidine
19
 Date of notification by the
Notifying country Prohibited substance Secretary-General
Togo (continued) Pipradrol
Secobarbital
Turkey Amfepramone 30 June 1981
Amfetamine
Dexamfetamine
Fenetylline 27 September 1999
Flunitrazepam
Metamfetamine 30 June 1981
Metamfetamine racemate 27 September 1999
Methaqualone 20 August 1982
Methylphenidate 30 June 1981
Pemoline 27 September 1999
Phendimetrazine 30 June 1981
Phenmetrazine
Phentermine
Pipradrol
United States of America Flunitrazepam 9 October 1996
Methaqualone 9 September 1985
Venezuela (Bolivarian Republic of) Amfetamine 2 June 1992
Dexamfetamine
Levamfetamine
Levomethamphetamine
Metamfetamine
Metamfetamine racemate
Methaqualone 22 May 1986
Phenmetrazine 2 June 1992
Yemen Amfetamine 18 November 1980
Ethinamate
Lefetamine (SPA)
Metamfetamine
Methaqualone
Methylphenidate
Methylphenobarbital
Methyprylon
Phencyclidine
Phenmetrazine
Pipradrol

20
 Notifications concerning the prohibition of and restrictions on export and import pursuant to
article 13 of the Convention on Psychotropic Substances 1971, by prohibited substance
Prohibited substance Notifying country

Aminorex India
Amfepramone India
Pakistan
Turkey
Amfetamine Belize
Bulgaria
Japan
Latvia
Lebanon
Lithuania
Nigeria
Pakistan
Senegal
Thailand
Togo
Turkey
Venezuela (Bolivarian Republic of)
Yemen
Barbital Pakistan
Brotizolam India
Benzfetamine India
Lebanon
Pakistan
Bromazepam India
Camazepam India
Pakistan
Cathine Latvia
Lebanon
Lithuania
Russian Federation
Clotiazepam India
Pakistan
Cloxazolam India
Pakistan
Cyclobarbital Pakistan
Delorazepam India
Pakistan
delta-9-tetrahydrocannabinol Lebanon
Dexamfetamine Belize
Bulgaria
Japan
Latvia
Lebanon
Lithuania
Nigeria
Pakistan
Senegal

21
Prohibited substance Notifying country
Thailand
Togo
Turkey
Venezuela (Bolivarian Republic of)
Yemen
Estazolam India
Ethchlorvynol Pakistan
Ethinamate India
Pakistan
Togo
Yemen
Ethyl loflazepate India
Pakistan
Etilamfetamine Latvia
Fenetylline Belize
Bulgaria
Latvia
Lebanon
Lithuania
Saudi Arabia
Thailand
Turkey
Fenproporex Latvia
Fludiazepam India
Flunitrazepam India
Lebanon
Pakistan
Turkey
United States of America
Flurazepam Pakistan
Glutethimide Chile
Pakistan
Halazepam Pakistan
Haloxazolam India
Pakistan
Ketazolam India
Lefetamine (SPA) Chile
India
Pakistan
Peru
Togo
Yemen
Levamfetamine Belize
Bulgaria
Japan
Latvia
Lebanon
Lithuania

22
Prohibited substance Notifying country
Thailand
Venezuela (Bolivarian Republic of)
Levomethamphetamine Belize
Japan
Lebanon
Thailand
Venezuela (Bolivarian Republic of)
Loprazolam India
Pakistan
Lormetazepam India
Mazindol India
Pakistan
Mecloqualone Argentina
Belize
Chile
Lebanon
Pakistan
Senegal
Togo
Medazepam India
Mefenorex Latvia
Mesocarb India
Metamfetamine Belize
Bulgaria
Japan
Latvia
Lebanon
Lithuania
Nigeria
Pakistan
Senegal
Thailand
Togo
Turkey
Venezuela (Bolivarian Republic of)
Yemen
Metamfetamine racemate Belize
Bulgaria
Japan
Latvia
Lebanon
Lithuania
Turkey
Venezuela (Bolivarian Republic of)
Methaqualone Argentina
Australia
Belize
Chile
Colombia

23
Prohibited substance Notifying country
Gabon
India
Lebanon
Madagascar
Nigeria
Pakistan
Saudi Arabia
Senegal
South Africa
Togo
Turkey
United States of America
Venezuela (Bolivarian Republic of)
Yemen
Methylphenidate Belize
Nigeria
Senegal
Thailand
Togo
Turkey
Yemen
Methylphenobarbital Pakistan
Togo
Yemen
Methyprylon India
Pakistan
Senegal
Togo
Yemen
Nordazepam Pakistan
Oxazolam India
Pakistan
Pemoline Nigeria
Togo
Turkey
Phencyclidine Belize
Chile
Iceland
Lebanon
Nigeria
Pakistan
Senegal
Togo
Yemen
Phendimetrazine India
Pakistan
Peru
Turkey

24
Prohibited substance Notifying country
Phenmetrazine Belize
Chile
Nigeria
Pakistan
Senegal
Thailand
Togo
Turkey
Venezuela (Bolivarian Republic of)
Yemen
Phentermine Latvia
Turkey
Pinazepam India
Pipradrol India
Pakistan
Thailand
Togo
Turkey
Yemen
Prazepam India
Secobarbital Belize
Nigeria
Pakistan
Togo
Temazepam India
Tetrazepam India
Pakistan
Triazolam Lebanon

25